Sutro Biopharma saw the highest growth of 2.99% in patent filings in May and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.24% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Sutro Biopharma‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Sutro Biopharma has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 67% filings and 100% grants. The United States(US), Australia(AU), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Sutro Biopharma is filings its patents. Among the top granted patent authorities, Sutro Biopharma has 100% of its grants in United States(US).
Roche could be the strongest competitor for Sutro Biopharma
Patents related to cell & gene therapy and nanomedicine lead Sutro Biopharma's portfolio
Sutro Biopharma has the highest number of patents in cell & gene therapy followed by, nanomedicine and rare diseases. For cell & gene therapy, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Leukemia related patents lead Sutro Biopharma portfolio followed by lymphoma, and breast cancer
Sutro Biopharma has highest number of patents in leukemia followed by lymphoma, breast cancer, bacterial infections, and advanced malignancy. For leukemia, nearly 50% of patents were filed and 12% of patents were granted in Q2 2024.
For comprehensive analysis of Sutro Biopharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
